![Andrew Anzalone](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Anzalone
Oprichter bij
PRIME MEDICINE, INC.
Profiel
Andrew Anzalone is the founder of Prime Medicine, Inc. and holds the title of Head-Prime Editing Platform since 2019.
Education includes an undergraduate degree from Brown University and a doctorate from The Trustees of Columbia University in The City of New York.
Actieve functies van Andrew Anzalone
| Bedrijven | Functie | Begin |
|---|---|---|
| PRIME MEDICINE, INC. | Oprichter | 13-09-2019 |
Opleiding van Andrew Anzalone
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
24
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Brown University
 Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prime Medicine, Inc.
 Prime Medicine, Inc. BiotechnologyHealth Technology Develops CRISPR gene editing technology | Health Technology |
